A coalition of drug reform advocates in Washington State have announced theyll seek to qualify a decriminalization measure for the states 2022 ballot, an attempt to build on modest reforms adopted by the states legislature during its most recent session.
While a draft of the prospective measure has yet been released, the group behind the proposal said in an email to supporters on Tuesday that its currently refining its language, which will be filed as a new initiative in January for the November 2022 ballot.
At a minimum, the group said, the initiative would make the following changes:
Signature gathering to qualify the prospective ballot measure would begin in February if all goes according to plan.
The group behind the measure, Commit to Change WA, was formerly known as Treatment First WA and in 2020 attempted to qualify a decriminalization measure for that years state ballot. That initiative would have made unlawful possession of any drug a civil infraction, referred people found with drugs to a services assessment, and funded a massive expansion of outreach and recovery programs.
When the pandemicinterrupted the signature gathering effortfor that measure, organizers shifted their focus to the legislature. After months of delay, House Bill 1499, largely based on the earlier initiative, was introduced this past February but eventually died after clearing one House committee.
The group said its name change reflects the fact that it is past time to change course on the drug warand communicates the need for drug policy solutions to take a whole-person approach.
Prioritizing treatment over incarceration is one important piece of a new approach, but repairing decades of damage caused by the War on Drugs requires a fundamental shift in paradigm, the group said, and a long-term commitment to tailoring prevention and recovery strategies to the specific needs of individuals and communitieswhether those needs are for treatment, housing, job training, mental health care, or other chronically under-resourced services.
State lawmakers earlier this year downgraded Washingtons criminal penalty for drug possession from a felony to a misdemeanor, but only under duress. Months earlier, the state Supreme Court had invalidated the states decades-old felony law, leaving no valid law on the books against simple possession. While more progressive Democrats urged against reinstating criminal penalties, the legislature ultimately adopted the misdemeanor charge along with plans to create a statewide suite of treatment and recovery services. The law, widely seen by advocates as a half-step toward meaningful reform,took effect in May with Gov. Jay Inslees (D) signature.
Commit to Change wants to undo the states re-criminalization of simple possession and dedicate sustained funding for a new system. While the legislatures compromise required the development of a statewide recovery plan, the group said, it didnt dedicate any funding for the services to be provided, leaving it to the legislature to decide whether and what to appropriate each budget cycle.
Regardless of what happens with Commit to Changes latest proposal, Washingtons new misdemeanor possession is already set to expire. As passed by the legislature earlier this year, the laws criminal penalty provision will dissolve on July 1, 2023, again leaving the state without a law against drug possession. That feature was included as an incentive for lawmakers to revisit the issue in coming years. The possibility of a decriminalization ballot measure in 2022 could create further pressure to act.
Meanwhile, out-of-state advocates are also eying Washington as among the next frontiers for drug reform at the ballot box. David Bronner, the CEO of soap company Dr. Bronners and a major funder of drug reform efforts, said at an event last week that he expects statewide measures in 2024 to decriminalize all drugs in at least three states: Washington, Californiaand Colorado.
No one should be further traumatized with arrest and incarceration who is struggling with addiction, he told Marijuana Moment in an email Wednesday, adding that there are specific provisions hes hoping to see adopted into the initiatives in Washington and elsewhere.
Im advocating to allies there that the all-drug decrim policy for possession should have substantially higher (ideally no) defined limits for personal possession for plant medicines than Measure 110 in Oregon, he wrote, referring to the drug decriminalization ballot measure that voters in that state approved last November.
Bronner is also pushing for proposed laws to allow for aggregating personal possession limits to cover facilitated and supported use.
Group healing with plant medicines is great for people struggling with addiction, by helping people process and heal the underlying trauma and emotional pain at issue, he said.
A task force based in Seattle, meanwhile, recently issued recommendations advising that local and municipal leaders decriminalize psychedelicsand eventually consider legalizing all drugsas one of a handful of policy changes designed to reduce opioid overdose deaths. Activists at the local group Decrim Nature Seattle have also submitted a draft psychedelics-decriminalization ordinance at the request of City Councilmember Andrew Lewis. Bronner said hes hopeful that DN Seattles resolution will be voted on and passed before the end of this year.
Nationwide, states and cities across the country have reconsidered their drug laws in the wake of the 2020 election, when voters in Oregon approved two separate statewide initiatives, onedecriminalizing possession of all drugsand another to legalize psilocybin, the main component of psychedelic mushrooms, for therapeutic use. Washington, DC also passed a measure decriminalizing plant- and fungi-based psychedelics.
In May, lawmakers in Congress filed the first-ever legislation to federally decriminalize possessionof illicit substances.
In California, the Senate approved a bill this year to legalize possession of psychedelics. If also cleared two Assembly committees, but its sponsor moved to pull it from further consideration until next year in order to have more time build support within the legislature to ensure passage.
Separately, psychedelics activists in the Golden State recently filed a petition for the 2022 ballot to make the state the first in the nation to legalize psilocybin mushrooms for any use. A fiscal analysis of the proposal found that it would save the state millions in enforcement costs and also generate state and local tax revenue. OaklandandSanta Cruzhave already enacted psychedelics decriminalization.
Michigan senators introduced a bill last week to legalize the possession, cultivation and deliveryof an array of plant- and fungus-derived psychedelics like psilocybin and mescaline. Locally, the Ann Arbor City Councilapproved entheogenic decriminalization last year, and efforts are also underway in Grand Rapids to enact a policy change for psychedelics. Voters in Detroit will decide on a psychedelics decriminalization ballot measure this November.
Meanwhile, Denver activists who successfully led a 2019 campaign to make the citythe first in the U.S. to decriminalize psilocybin possessionhave their eyes set on broader reform, with plans in the works to end the criminalization of noncommercial gifting and communal use of the psychedelic.
In a setback for advocates of broader research into controlled substances, however, the U.S. House of Representatives recently voted against a proposal from Rep. Alexandria Ocasio-Cortez (D-NY) thatwould have removed a spending bill riderthat advocates say has restricted federal funds for research into Schedule I drugs, including psychedelics such as psilocybin, MDMA and ibogaine. However, the proposal picked up considerably more votes this round thanwhen the congresswoman first introduced itin 2019.
Read a description of the proposed Washington drug decriminalization ballot measure below:
Washington Drug Decriminalization Campaign by Marijuana Moment on Scribd
World Anti-Doping Agency Reviews Marijuana Ban For Athletes Following Pushback On Richardson Suspension
- Study Finds 65% Of Americans With Mental Health Conditions Want Access To Psychedelics - Forbes - January 24th, 2022
- What are the potential risks of microdosing psychedelics? - Leafly - January 24th, 2022
- Trade To Black Podcast 20: Is the Selling In MSOS And Psychedelics Getting Overdone? A Frank Discussion - The Dales Report - January 24th, 2022
- Icebreakers with...MindMed CEO Rob Barrow - Morning Brew - January 24th, 2022
- Research in 60 Seconds: How Taking Psychedelics Can Be Therapeutic - UCF - January 24th, 2022
- TDRs Top 5 Psychedelic Developments For The Week Of January 17 - The Dales Report - January 24th, 2022
- The Psychedelics Series: The history and future of ketamine - The Cannabis Exchange - January 24th, 2022
- How 2021 became the year of psychedelics - and why 2022 is set to be even bigger - The Cannabis Exchange - January 24th, 2022
- Why Is Everyone Smoking Toad Venom? - What To Know About the Hallucinogenic Toad, DMT, Bufo - TownandCountrymag.com - January 24th, 2022
- Breaking Down Numinus Wellness Quarterly Results - The Dales Report - January 24th, 2022
- Ancient Latin American Empire Could Have Thrived Thanks to Psychedelic-Infused Beer - StreetInsider.com - January 24th, 2022
- Psychedelics can change humanity for the better. Its time ... - January 9th, 2022
- 'Microdosers' of LSD and magic mushrooms are wiser... - Daily Maverick - January 9th, 2022
- Core One Labs Now Also Working to Biosynthesize DMT and Receives License - Financial Post - January 9th, 2022
- NeonMind to Present at H.C. Wainwright Bioconnect Conference - Yahoo Finance - January 9th, 2022
- Magic mushroom companies are on the Nasdaq now. Thats a recipe for a bad trip - The Guardian - January 7th, 2022
- Psilocybin therapy options could expand in Hawaii | Hawai'i Public Radio - Hawaiipublicradio - January 7th, 2022
- From psychedelics to 'The Great Resignation' - wellness trends for 2022 - CapeTown ETC - January 7th, 2022
- Ketamine, Psilocybin and the Rise of Missouri Psychedelics - Riverfront Times - December 25th, 2021
- Animals That Eat Psychedelics And Enjoy The Trip - Benzinga - Benzinga - December 25th, 2021
- Bad Hug - The Cut - December 25th, 2021
- How Seeing God Might Be The Secret To The Most Cutting-Edge Mental Health Treatments - Forbes - December 25th, 2021
- Happy Holidays From The Dales Report Team - The Dales Report - December 25th, 2021
- GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs - Marijuana Moment - December 22nd, 2021
- Meet Zappy Zapolin, The Psychedelic Concierge Who Turned Lamar Odom On To Ketamine - Forbes - December 22nd, 2021
- Numinus Wellness inc: Leading in the psychedelics race - Proactive Investors UK - December 22nd, 2021
- When Aldous Huxley Opened the Doors of Perception - The MIT Press Reader - December 22nd, 2021
- Kratom Attracts Investor Attention After Regulatory Win - Bloomberg - December 22nd, 2021
- Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so... - December 22nd, 2021
- Revenge travel and psychedelic retreats: The travel trends taking flight in 2022 - AsiaOne - December 22nd, 2021
- Cybin Awarded Notice of Allowance from US Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety... - December 15th, 2021
- TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions - ABC News - December 15th, 2021
- PharmaTher Announces Positive Research Results for LSD Microneedle Patch - Yahoo Finance - December 15th, 2021
- MDMA could soon be used to treat PTSD according to physicians - Mixmag - December 15th, 2021
- MindMed Appoints Robert Barrow as Chief Executive Officer and Director - Yahoo Finance - December 15th, 2021
- MAPS and Wesana Health Resume Negotiations - GlobeNewswire - December 15th, 2021
- Sex, psychedelics and murderous impulses: Do we know too much about Will Smith? - The Independent - November 7th, 2021
- PharmaDrug commissions TIBI for advancing psychedelics program with analogue DMT formulation to cure eye diseases - Proactive Investors USA - November 7th, 2021
- I Have $1,000. Should I Invest In Cannabis, Crypto Or Psychedelics? - Benzinga - Benzinga - November 7th, 2021
- Psychedelics Could Be New Frontier in End-of-Life Care - Hospice News - November 5th, 2021
- Detroit just decriminalized psychedelics and magic mushrooms. Heres what that means - PBS NewsHour - November 5th, 2021
- Psychedelics linked to lower risk of heart disease and diabetes - Medical News Today - November 5th, 2021
- The people turning to psychedelics on their deathbeds - The Independent - November 5th, 2021
- Psychedelic Therapy Is Hyped, But Its Not Risk-Free: How Therapy Abuse Can Retraumatize Clients - Forbes - November 5th, 2021
- Defeating Gambling Addiction: New Study Looks To Defy The Odds With Psychedelics - Forbes - November 5th, 2021
- This Psychedelics Unicorn's Stock Is Up 50% In One MonthBeating Bitcoin, Ethereum And Dogecoin - Benzing - Benzinga - November 5th, 2021
- This Psychedelics Stock Was Up More Than 20% Last Week, Outperforming Tesla, Nvidia and GameStop - Benzinga - November 5th, 2021
- Biglaw Associate Is Advocating For Therapeutic Use Of Psychedelics And The Firm Is Backing Him Up - Above the Law - November 5th, 2021
- Easthampton is the fourth city in Mass. to vote to decriminalize psychedelics - WBUR - October 24th, 2021
- There Could Be a Curious Link Between Psychedelics And Improved Heart Health - ScienceAlert - October 24th, 2021
- How Atai Is Transforming The Landscape Of Mental Health Using Psychedelics (Part 2) - Forbes - October 24th, 2021
- A recent history of therapeutic psychedelics - Toronto Life - October 24th, 2021
- New Research Hints at a Link Between Psychedelics and Improved Heart Health - The Swaddle - October 24th, 2021
- Why Ketamine-Assisted Therapy Has Gone Mainstream - Forbes - October 24th, 2021
- Ketamine and psilocybin, better known as party drugs, showing promise for treatment of mood disorders - CTV News - October 24th, 2021
- Recent progress in psychedelic therapies - Lexology - October 24th, 2021
- Miracles and medication: The new science of psychedelic drugs - Stuff.co.nz - October 24th, 2021
- UAB researcher granted federal funding for psilocybin and smoking study - The Mix - October 24th, 2021
- Yale researchers using psychedelics to find new treatments for depression - WTNH.com - September 17th, 2021
- Want Quick Exposure To The Psychedelics Sector? Check Out This New Active ETF - Benzinga - Benzinga - September 17th, 2021
- 5 things to know about the Ann Arbor psychedelic shroom fest - MLive.com - September 17th, 2021
- A Look At Psychedelics Stock PharmaTher And Its Recent Bull Run - Benzinga - Benzinga - September 17th, 2021
- Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) -... - September 17th, 2021
- Psychedelics research and public education elevated by multiple gifts - UC Berkeley - September 16th, 2021
- Pain Awareness Month: Psychable Educates Patients on Transformative Power of Using Psychedelics as Medicine for Pain Treatment, Management and Healing... - September 16th, 2021
- $80 Million Granted to Research Psychedelic Properties of Ingesting Toad Venom - Newsweek - September 16th, 2021
- Psychedelic Use on the Rise As Gen Z Seeks To Enhance Connectedness - VICE UK - September 16th, 2021
- Phyto Partners Cannabis VC on Why He's Investing in Psychedelics - Business Insider - September 16th, 2021
- Seattle bid to decriminalize psychedelics could have profound effect on treating addiction - MyNorthwest.com - September 16th, 2021
- Post-9/11 vets go to Mexico to treat trauma with psychedelic - The San Diego Union-Tribune - September 16th, 2021
- Lobe Sciences to Participate at the Advances in Me... | INN - Investing News Network - September 16th, 2021
- Seattle is now in the process of legalizing psychedelics, heres what to know - Curiocity - September 16th, 2021
- World Suicide Prevention Day: Suicide Remains a Leading Global Cause of Death; Communities Across the World Seek Expanded Use of Psychedelics as... - September 16th, 2021
- Psilocybin Transdermal Patches Could Be The Next Big Thing In Psychedelics - Forbes - September 1st, 2021
- Psychedelics are getting closer to approval, but the market may not be ready - FierceBiotech - August 22nd, 2021
- At-Home Genetic Testing Cant Tell You If Youre Going to Have a Bad Trip - VICE - August 22nd, 2021
- Past, Present & Future of Psychedelic-Assisted Therapy: A New Dawn for Mental Health and Neuroscience - cmc.edu - August 22nd, 2021
- Researchers breaking away from the central dogma of depression - STAT - STAT - August 22nd, 2021
- When did humans start experimenting with alcohol and drugs? - EL PAS in English - August 22nd, 2021
- Origin Therapeutics Will Invest $5.1M In Psychedelics Startups - Yahoo Finance - August 14th, 2021